Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 11|pp. 15413–15432
Sex-related differences in the efficacy of immune checkpoint inhibitors in malignancy: a systematic review and meta-analysis
Back to articleFigure 3(3 of 6)
100%
Figure 3
Figure 3.Progression-free survival hazard ratio in male patients in the immune checkpoint inhibitor group compared with the control group.
Figure 3 — Sex-related differences in the efficacy of immune checkpoint inhibitors in malignancy: a systematic review and meta-analysis | Aging